|
October 27, 2010
|
Terry Schlotterback, Ex-Zimmer Executive, Joins Affinergy Board of Directors
28 Years of Orthopedic Expertise Strengthen Affinergy Commercialization Plans
RESEARCH TRIANGLE PARK, N.C., October 27, 2010 - Affinergy announced today that Terry Schlotterback has joined its Board of Directors. Schlotterback spent 20 years with Zimmer, most recently in two key leadership roles as President of Zimmer Trauma Division and President of Zimmer Spine Division. Previously, he served as Vice President at Zimmer in Sales, Product Development, and Global Marketing Services roles as well as leadership roles at Depuy and Mitek Surgical Products, divisions of Johnson and Johnson. Affinergy develops medical devices for use in orthopedics, sports medicine, and general surgery.
"Affinergy's robust product pipeline and compelling vision for growth gives me great enthusiasm to actively support this drive to commercial success," said Mr. Schlotterback. "These products can improve patient outcomes while simultaneously containing healthcare costs. I am confident that surgeons will be eager to incorporate these proprietary products into their practices and distributors will find them to be valuable additions to their offerings."
"Terry has a unique combination of experiences across orthopedic markets as well as across functional areas such as product development, sales, and executive leadership," said Peyton Anderson, CEO of Affinergy. "He has already proven to be a tremendous advisor in terms of our product development and hiring plans for the Affinergy commercialization team. Terry's expertise and deep industry connections will be critical to our long term growth plans. On a personal level, Terry is a thoughtful mentor with impeccable integrity who is deeply committed to improving patient outcomes."
Mr. Schlotterback currently serves on the Board of Directors at Orthopediatrics which is developing specialized orthopedic products for children. He lives outside of Warsaw, Indiana.
About Affinergy, Inc.
Affinergy develops medical devices for use in orthopedics, sports medicine, and general surgery. Affinergy's technology was licensed from Duke University and was awarded 2005 Innovation of the Year by Frost & Sullivan in the category of Medical Device Coatings. For more information, visit www.affinergy.com.
For more information:
Peyton Anderson
Chief Executive Officer
Affinergy, Inc.
919-433-2229
panderson@affinergy.com
|
